Specifically, CD184+/CD184− ratio analysis provided a more nuanced understanding of how SDF-1 signaling through the CXCR4 receptor is differentially regulated in neonates with moderate encephalopathy compared to those with severe encephalopathy. This evidence concerns the gene CXCL12 and Encephalopathy.